Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells

US Patent 7105156 · Granted Sep 12, 2006

Estimated economic value: $71,279,000

Assignee

Inventors

View full patent text on Google Patents →